Founded by Sarvjeet and Tajinder Singh Virk in 2009, Finvasia has matured into a multifaceted global ecosystem spanning financial services, healthcare, biomedical engineering, and investment banking. With over five million clients across 190+ countries, its groundbreaking ventures include Shoonya (zero-commission trading), ZuluTrade (social trading), Jumpp (AI-powered neo-banking), Ethniq (plant-based medicine), Bodyloop (in-body sensors), and Gini Health (DNA-based diabetes reversal) all driving accessibility, transparency, and innovation.